The enzyme activity of 12-hLO was determined by a direct measurement of product formation by monitoring the absorbance at 234 nm in a 2 mL cuvette. IC50 values of inhibitors were obtained by measuring the enzymatic rate at a variety of concentrations (Carroll et al, Segraves et al). ..more
Related BioAssays
Related BioAssays
Target
| Sequence: arachidonate 12-lipoxygenase [Homo sapiens] Protein Family: Lipoxygenase Gene:ALOX12 Related Protein 3D Structures |
BioActive Compounds: 21
Depositor Specified Assays
Show more |
| AID | Name | Type | Comment |
|---|---|---|---|
| 1452 | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | confirmatory | primary qHTS assay for 12hLO |
| 2162 | Confirmation qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | confirmatory | |
| 2163 | Cuvette-Based Assay for Inhibitors of 12-hLO (12-human lipoxygenase): 8HQ Series - Round 1 | confirmatory | |
| 2584 | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) - Confirmatory and Counterscreen Data | confirmatory | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) - Confirmatory and Counterscreen Data |
| 2164 | Probe Development Summary of Inhibitors of 12-hLO (12-human lipoxygenase) | summary | Probe Development Summary of Inhibitors of 12-hLO (12-human lipoxygenase) |
| 493209 | Activators of 12-hLO (12-human lipoxygenase): 12hLO Cuvette-Based Hit Validation Assay of Followup Compounds | confirmatory | |
| 493220 | Inhibitors of 12-hLO (12-human lipoxygenase): 15hLO-1 Cuvette-Based Inhibition Counterscreen Assay for 12hLO Followup Compounds | confirmatory | |
| 493216 | Inhibitors of 12-hLO (12-human lipoxygenase): Cuvette-Based Hit Assay for Validation of Followup Compounds | confirmatory | |
| 493219 | Inhibitors of 12-hLO (12-human lipoxygenase): 15hLO-1 Cuvette-Based Activation Counterscreen Assay for 12hLO Followup Compounds | confirmatory |
Description:
Assay Provider: Holman, T.R., University of California, Santa Cruz
Screening Center PI: Austin, Christopher P.
Screening Center: NIH Chemical Genomics Center
The enzyme activity of 12-hLO was determined by a direct measurement of product formation by monitoring the absorbance at 234 nm in a 2 mL cuvette. IC50 values of inhibitors were obtained by measuring the enzymatic rate at a variety of concentrations (Carroll et al, Segraves et al).
Screening Center PI: Austin, Christopher P.
Screening Center: NIH Chemical Genomics Center
The enzyme activity of 12-hLO was determined by a direct measurement of product formation by monitoring the absorbance at 234 nm in a 2 mL cuvette. IC50 values of inhibitors were obtained by measuring the enzymatic rate at a variety of concentrations (Carroll et al, Segraves et al).
Protocol
For control experiments, 2 mL of substrate buffer (10 uM arachidonic acid / 25 mM HEPES / 0.01% (v/v) Triton X-100, pH 8.0) was aliquoted in a cuvette with a magnetic stir bar. After equilibrium was ensured, an aliquot of inhibitor solvent was added (DMSO), and equilibrium was once again assured. The reaction was started by adding enzyme to the cuvette and the reaction was followed until completed. The inhibition experiments were performed as above, except the actual inhibitory compound was added instead of vehicle. To achieve an IC50, typically 5 concentrations of the inhibitor were studied. If the inhibitor concentration was constant, then five different reaction volumes were used.
Step \ Parameter \ Value \ Description
1; UV-Vis; 234 nm; Equilibration
2; Reagent; 2 mL; Substrate buffer
3; UV-Vis; 234 nm; Equilibration
4; Reagent; varies; Compound
5; UV-Vis; 234 nm; Equilibration
6; Reagent; 50-200 nM; Enzyme 12-hLO
7; UV-Vis; 234 nm; Enzymatic reaction
Step \ Notes
1; Blank cuvette to air.
2; 10 uM AA, 25 mM HEPES, 0.01% Triton X-100, pH 8.
3; No change in absorbance ensured.
4; Compound vehicle or compound in various concentrations depending on potency.
5; No change in absorbance ensured.
6; Enzyme concentration to achieve reaction rate between 0.02 and 0.04 AU/s.
7; Enzymatic reaction visualized until completion.
Step \ Parameter \ Value \ Description
1; UV-Vis; 234 nm; Equilibration
2; Reagent; 2 mL; Substrate buffer
3; UV-Vis; 234 nm; Equilibration
4; Reagent; varies; Compound
5; UV-Vis; 234 nm; Equilibration
6; Reagent; 50-200 nM; Enzyme 12-hLO
7; UV-Vis; 234 nm; Enzymatic reaction
Step \ Notes
1; Blank cuvette to air.
2; 10 uM AA, 25 mM HEPES, 0.01% Triton X-100, pH 8.
3; No change in absorbance ensured.
4; Compound vehicle or compound in various concentrations depending on potency.
5; No change in absorbance ensured.
6; Enzyme concentration to achieve reaction rate between 0.02 and 0.04 AU/s.
7; Enzymatic reaction visualized until completion.
Comment
Keywords: NIH Roadmap, MLSCN, MLPCN, MLI, MLSMR, qHTS, NCGC, human
lipoxygenase, 12hLO, 12-hLO
Compound Ranking:
For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given based on -Log[Potency*10^-6]
lipoxygenase, 12hLO, 12-hLO
Compound Ranking:
For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given based on -Log[Potency*10^-6]
Result Definitions
| TID | Name | Description | Histogram | Type | Unit | |
|---|---|---|---|---|---|---|
| Outcome | The BioAssay activity outcome | Outcome | ||||
| Score | The BioAssay activity ranking score |  | Integer | |||
| 1 | Phenotype | Indicates type of activity observed: inhibitor, activator, fluorescent, cytotoxic, inactive, or inconclusive. | String | |||
| 2 | Potency* | Concentration at which compound exhibits half-maximal efficacy, IC50. Extrapolated IC50s also include the highest efficacy observed and the concentration of compound at which it was observed. | | Float | μM |
* Activity Concentration.
Additional Information
Grant Number: MH081283-01
Data Table (Concise)
Classification
PageFrom: